Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force
Cynthia Delgado, Mukta Baweja, Nilka Rı́os Burrows, et al.
Journal of the American Society of Nephrology (2021) Vol. 32, Iss. 6, pp. 1305-1317
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
Paul E. Stevens, Sofia B. Ahmed, Juan Jesús Carrero, et al.
Kidney International (2024) Vol. 105, Iss. 4, pp. S117-S314
Open Access | Times Cited: 1904
A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease
Cynthia Delgado, Mukta Baweja, Deidra C. Crews, et al.
Journal of the American Society of Nephrology (2021) Vol. 32, Iss. 12, pp. 2994-3015
Open Access | Times Cited: 243
RNA profiles reveal signatures of future health and disease in pregnancy
Morten Rasmussen, Mitsu Reddy, Rory Nolan, et al.
Nature (2022) Vol. 601, Iss. 7893, pp. 422-427
Open Access | Times Cited: 141
Health inequities and the inappropriate use of race in nephrology
Nwamaka D. Eneanya, L. Ebony Boulware, Jennifer Tsai, et al.
Nature Reviews Nephrology (2021) Vol. 18, Iss. 2, pp. 84-94
Open Access | Times Cited: 105
Eliminating Race-Based Medicine
Joseph L. Wright, Wendy S. Davis, Madeline Joseph, et al.
PEDIATRICS (2022) Vol. 150, Iss. 1
Closed Access | Times Cited: 96
Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database
David Alfego, Jennifer L. Ennis, Barbara S. Gillespie, et al.
Diabetes Care (2021) Vol. 44, Iss. 9, pp. 2025-2032
Open Access | Times Cited: 69
Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population
Edouard L. Fu, Josef Coresh, Morgan E. Grams, et al.
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 1, pp. 119-128
Open Access | Times Cited: 44
The failing kidney allograft: A review and recommendations for the care and management of a complex group of patients
Michelle Lubetzky, Ekamol Tantisattamo, Miklos Z. Molnar, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 9, pp. 2937-2949
Open Access | Times Cited: 45
Time to Eliminate Health Care Disparities in the Estimation of Kidney Function
Winfred W. Williams, Joseph W. Hogan, Julie R. Ingelfinger
New England Journal of Medicine (2021) Vol. 385, Iss. 19, pp. 1804-1806
Open Access | Times Cited: 41
Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care
Edouard L. Fu, Andrew S. Levey, Josef Coresh, et al.
Nephrology Dialysis Transplantation (2023) Vol. 39, Iss. 4, pp. 694-706
Open Access | Times Cited: 19
Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study
Alexander H. Flannery, Victor Ortiz-Soriano, Xilong Li, et al.
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 34
The New 2021 CKD-EPI Equation Without Race in a European Cohort of Renal Transplanted Patients
Pierre Delanaye, Ingrid Masson, Nicolas Maillard, et al.
Transplantation (2022) Vol. 106, Iss. 12, pp. 2443-2447
Open Access | Times Cited: 25
Accuracy of the New Creatinine-based Equations for Estimating Glomerular Filtration Rate in Koreans
Tae‐Dong Jeong, Jinyoung Hong, Woochang Lee, et al.
Annals of Laboratory Medicine (2022) Vol. 43, Iss. 3, pp. 244-252
Open Access | Times Cited: 24
Diagnostic standard: assessing glomerular filtration rate
Pierre Delanaye, Hans Pottel, Étienne Cavalier, et al.
Nephrology Dialysis Transplantation (2023) Vol. 39, Iss. 7, pp. 1088-1096
Closed Access | Times Cited: 14
Management of chronic kidney disease in type 2 diabetes: screening, diagnosis and treatment goals, and recommendations
Jay H. Shubrook, Joshua J. Neumiller, Eugene E. Wright
Postgraduate Medicine (2021) Vol. 134, Iss. 4, pp. 376-387
Open Access | Times Cited: 30
Prediction of End-Stage Kidney Disease Using Estimated Glomerular Filtration Rate With and Without Race
Joshua D. Bundy, Katherine T. Mills, Amanda H. Anderson, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 3, pp. 305-313
Open Access | Times Cited: 21
Development and validation of a new equation based on plasma creatinine and muscle mass assessed by CT scan to estimate glomerular filtration rate: a cross-sectional study
Thomas Stehlé, Yaniss Ouamri, Antoine Morel, et al.
Clinical Kidney Journal (2023) Vol. 16, Iss. 8, pp. 1265-1277
Open Access | Times Cited: 11
Development and validation of a race-agnostic computable phenotype for kidney health in adult hospitalized patients
Tezcan Ozrazgat‐Baslanti, Yuanfang Ren, Esra Adıyeke, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0299332-e0299332
Open Access | Times Cited: 4
The Use of Cystatin C as a Marker of Glomerular Filtration Rate in Clinical Practice
Flávio Reis, Elias David‐Neto
IntechOpen eBooks (2025)
Closed Access
Embedding equity, diversity and inclusion processes within clinical trials and health and social care research
Keerti Gedela, Richard J. Wong, Suki Balendra, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e091807-e091807
Open Access
Population‐level impact of semaglutide 2.4 mg in patients with obesity or overweight and cardiovascular disease: A modelling study based on the SELECT trial
Michael G. Nanna, Quan V. Doan, Anthony N. Fabricatore, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Implementing use of cystatin C‐guided estimated glomerular filtration rate for medication dosing at an Academic Medical Center
Victoria Williams, Rupal K. Parbhoo, Bruce Doepker, et al.
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2025)
Open Access
Management of acute kidney disease as part of routine clinical care in low-resource settings: The International Society of Nephrology Kidney Care Network Project
Rhys Evans, Sanjib Kumar Sharma, Rolando Claure‐Del Granado, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0315802-e0315802
Open Access
Improved Performance in Measurement of Serum Cystatin C by Laboratories Participating in the College of American Pathologists 2019 CYS Survey
Amy B. Karger, Thomas Long, Lesley A. Inker, et al.
Archives of Pathology & Laboratory Medicine (2022) Vol. 146, Iss. 10, pp. 1218-1223
Open Access | Times Cited: 16
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease
Hugh Gallagher, Jennifer Dumbleton, Tom Maishman, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top